An epidemic of mpox has claimed one life and infected four others in South Africa, the government announced on Wednesday, stating measures are being taken to procure additional treatment medications as a precautionary measure.
The five reported cases, occurring between May 8 and June 7, represent the first instances recorded in the nation since 2022, according to statements made by Health Minister Joe Phaahla during a press conference.
Phaahla emphasized the importance of early medical intervention and contact tracing for those presenting symptoms associated with mpox, a viral illness previously referred to as monkey-pox. The disease is transmitted through close contact with infected individuals or animals, as well as contaminated materials like bedding.
Symptoms of mpox include skin lesions, fever, headache, muscle pain, and swollen lymph nodes, as outlined by the World Health Organization (WHO). Initially identified in humans in 1970 in the Democratic Republic of Congo, the disease has primarily affected West and Central African countries.
A significant rise in global mpox infections, particularly among men who have sex with men, prompted the WHO to declare a global health emergency in May 2022. Although the alert was lifted in the past year, sporadic cases of transmission persist around the world.
Recent data from the WHO reveals more than 97,000 cases and 186 fatalities reported across 117 countries in the early months of 2024. Phaahla noted that the individuals recently infected in South Africa were all males in their 30s, with cases being classified as severe. Two patients are still admitted to the hospital for treatment.
In light of the current situation, efforts are underway to secure a stockpile of Tecovirimat treatment for potential rapid deployment in the event of a broader outbreak, according to Phaahla, referencing an antiviral medication.
